A Single-centre Research Study to Evaluate the Care4Today® Heart Failure Platform.
- Conditions
- Heart Failure With Reduced Ejection Fraction
- Interventions
- Other: Care4todayheart failure platform
- Registration Number
- NCT04371731
- Lead Sponsor
- Buckinghamshire Healthcare NHS Trust
- Brief Summary
A research study to evaluate the impact of a novel care pathway for patients diagnosed with Heart Failure within Chiltern CCG, supported by an integrated clinical patient record. Assessment of patient outcomes following implementation of Care4Today(R) Heart Failure Platform.
- Detailed Description
This is an exploratory study to evaluate the impact of the novel Care4Today HF platform on a set of outcomes including hospital admission rate (primary diagnosis), 30 days post discharge readmission rate, length of hospital stay for patients with HF (primary and secondary diagnosis), patient quality of life, and patient clinical metrics. The study design includes comparison of two parallel cohorts: one where patients will be managed via the Care4Today HF platform (active cohort) and a second, where patients will be managed as per existing standards of care (control cohort).
Evaluation phase:
The evaluation phase will be set up to assess the potential benefits of the Care4Today HF platform. This will be implemented across 10 GP practices who will be part of the active cohort, within the Chiltern CCG region. The outcomes for these patients will be compared with the outcomes of patients in the control cohort over a one year period.
Patients pathway (for the active cohort):
Once the diagnosis of HF is confirmed, a HF specialist project nurse will register the patient on the Care4Today platform and provide the patient with instructions on how to use the patient portal, where patients can input various clinical measures, communicate with HCPs and track their condition. Complex patients, and/or patients that are deteriorating are referred to the community HF specialist nurse team where they will be monitored and managed.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 182
- Adults 18 years of age or older with the primary diagnosis of heart failure
- Must have moderate to severe LVSD (ejection fraction <= 40%) confirmed by an echocardiogram and/or other cardiac imaging
- Patients with right heart failure as a consequence of respiratory disease
- Patients with Heart Failure with preserved Ejection Fraction
- Patients with significant learning disability, or severe mental health conditions
- Patients with metabolic heart disease e.g. amyloid
- Patients with severe non-operable valve disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Active Arm Care4todayheart failure platform Active cohort will use the Care4today platform to help manage their heart failure
- Primary Outcome Measures
Name Time Method Hospital admissions 12 months number of hospital admissions
- Secondary Outcome Measures
Name Time Method QOL 12 months o Mean change in Quality of Life assessed by Minnesota Living with Heart Failure Questionnaire and EQ5D or EQVAS
mean number of heart failure readmissions within 30 days of discharge 30 days of discharge mean number of heart failure readmissions within 30 days of discharge
length of stay 12 months o Mean, median (SD) days of length of stay (for admissions with a primary and secondary diagnosis of HF)
weight change 12 months Mean (SD) change in weight
all cause readmissions 12 months mean number of all cause readmissions
Blood pressure 12 months o Proportion of patients achieving target for blood pressure (140/90mmHg or 130/80mmHg for patients with diabetes) at the end of the study
Hospital Anxiety and Depression Scale score 12 months Mean change in Hospital Anxiety and Depression Scale (HADS) at the start and after 1 year the end of the study. Score on scale of 0-21, 0-7 = normal, 8-10 borderline, 11-21 abnormal. Higher score = worse outcome